Myriad RBM Revenue and Competitors

Austin, TX USA

Location

$25M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Myriad RBM's estimated annual revenue is currently $34.3M per year.(i)
  • Myriad RBM's estimated revenue per employee is $193,750
  • Myriad RBM's total funding is $25M.

Employee Data

  • Myriad RBM has 177 Employees.(i)
  • Myriad RBM grew their employee count by -41% last year.

Myriad RBM's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Myriad RBM?

Myriad RBM, Inc. is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers strategic biomarker services that include companion diagnostics, custom assay development, co-sponsored research programs, and innovative cell culture products. Myriad RBM's biomarker testing laboratory is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN).

keywords:N/A

$25M

Total Funding

177

Number of Employees

$34.3M

Revenue (est)

-41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Myriad RBM News

2022-04-20 - Nervous System Markers Market Segmented by Product, Application ...

Myriad RBM AbaStar MDx. QIAGEN Thermo Fisher Scientific. Region Segmentation North America (United States, Canada, Mexico) South America (Brazil, Argentina,...

2022-04-20 - Major Player in the Central Nervous System (CNS) Biomarkers ...

... While the Coronavirus Pandemic Has a Higher Impact: AbaStar MDX, Apitope International, ExonHit Therapeutics, Metabolon Inc., Myriad RBM.

2022-04-17 - Neurological Biomarkers Market Growth, Opportunity and Future ...

Myriad RBM Proteome Sciences Thermo Fisher Scientific Athena Diagnostics Immunarray Pvt. Ltd. Quanterix Corporation Diagenic ASA

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.5M17710%N/A
#2
$28.2M177N/AN/A
#3
$56.5M177-3%N/A
#4
$39.9M177N/AN/A
#5
$51.4M177-1%$154.2M